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IntRoDUCtIon
In recent years there has been a growing ten-
dency to include patients’ subjective assessment 
of treatment in medical results. This requires re-
search concerning problems of quality of life 
(QOL), which reflects patients’ subjective expe-
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Summary
Introduction: Studies have shown that successful percutaneous coronary interventions (PCI) in coronary 
artery disease patients are associated with significant improvement in quality of life (QOL). However, this 
notion has been challenged by reports of some discrepancy between the cardiological outcome of PCI and 
QOL improvement.
Aim: to assess the relationship between depressive symptoms and the QOL in CAD patients after success-
ful PCI.
Subjects	and	methods: Of 227 CAD patients, qualified for PCI, 156 with optimal PCI result were included. 
Patients were assessed one day prior, then 1 month, 6 months and 1 year after PCI, using the Polish version 
of the SF–36 questionnaire, the Beck Depression Inventory and the Hamilton Depression Rating Scale.
Results: In the entire study group QOL as measured 1 month after PTCA indicated significant improve-
ment. This tendency persisted in subsequent examinations. The presence of depressive disorders record-
ed one day prior to PCI served as a basis to identify group I (n=75) – patients with depressive disorders 
before PCI and II (n=81) – patients without depressive symptoms. On each occasion QOL in group I was 
significantly poorer than in group II, both with respect to the total QOL and individual components meas-
ured by 8 subscales of the SF–36. There was a significant correlation between QOL and severity of depres-
sive symptoms.
Conclusions: The present findings indicate that depressive disorders in patients with CAD – even after suc-
cessful intervention – significantly affect the QOL. Successful intervention and restoration of coronary arter-
ies are not the only determinants of satisfactory improvement in the QOL of cardiac patients.
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rience and their reactions to health, mental state, 
physical and social functioning, as well as non-
medical aspects of life [1, 2, 3, 4].
Studies concerning the effectiveness of percu-
taneous coronary interventions (PCI) in patients 
with coronary artery disease (CAD) have shown 
that revascularization is associated with signifi-
cant improvement in QOL [5, , 7, 8]. Recently, 
however, this notion has been challenged by re-
ports of some discrepancy between the cardio-
logical outcome of PCI and QOL improvement 
[9]. Although the interventions proved to be ef-
fective, a number of patients found that their 
general sense of well-being and life activity was 
impaired. Earlier studies of QOL in CAD patients 
neglected to address the problem of comorbid 
depressive disorders. These disorders constitute 
a serious clinical problem due to both their high 
rate of occurrence and negative impact on prog-
nosis [10, 11].
AIM	oF	tHe	StUDy
The aim of the present study was to assess the 
relationship between depressive symptoms and 
the QOL in CAD patients after successful PCI.
SUBJeCtS	AnD	MetHoDS
Two hundred and twenty seven patients diag-
nosed with CAD (CCS II-III), with no previous 
history of PCI or coronary artery bypass graft-
ing (CABG), qualified for an elective PCI (bal-
loon angioplasty, angioplasty with stent implan-
tation, rotational atherectomy) were enrolled in 
the study. Successful outcome of intervention, as 
well as lack of recurrent symptoms of ischemia 
during the four weeks following the interven-
tion, made the patient eligible for further anal-
ysis. PCIs were performed according to gener-
ally accepted standards of practice. The inter-
ventional cardiologist’s task was to achieve an 
optimal result for the procedure, which was de-
fined as final diameter stenosis < 30% (estimated 
in quantitative coronary angiography) without 
a high grade of dissection with good coronary 
flow (TIMI 3). Stents were used for an abrupt or 
threatened vessel closure, as well as in the case 
of a suboptimal result of balloon angioplasty (fi-
nal diameter stenosis < 20% was recognized as 
an optimal result of stent implantation). The in-
terventional cardiologists were permitted to use 
intravascular ultrasonography for additional op-
timalization of intervention. The clinically suc-
cessful PCI was defined as an angiographical-
ly effective procedure without serious compli-
cations, in conjunction with a reduction of clini-
cal symptoms. Patients with one menial vascular 
disease, as well as those who had multivessel de-
terioration were included in the study. PCIs were 
performed either as non-staged or staged proce-
dures during a one-day inpatient stay.
Symptoms of angina were assessed prior to 
PCI and four weeks subsequent to the interven-
tion using classification endorsed by the Canadi-
an Cardiovascular Society (CCS) [12]. In the in-
stances of atypical chest pain subsequent to PCI, 
an evaluation of myocardial ischemia was de-
termined by the results of an exercise test. Only 
those patients with complete functional revas-
cularization were included in the study sample.
All patients completed the Polish version of the 
SF–3 questionnaire and instrument, widely ac-
cepted for QOL assessment in somatic diseas-
es1, the Beck Depression Inventory (BDI). Addi-
tionally, the Hamilton Depression Rating Scale 
(HDRS) was administered [13, 14, 15, 1, 17, 18]. 
A patient was classified as being depressed ac-
cording to the results of the clinical examina-
tion and BDI, HDRS scores. Since the validity 
of depression rating scales and inventories may 
be problematic in patients with concurrent so-
matic illnesses, it has been suggested in the pro-
fessional literature that the higher cutoff scores 
should be used to determine diagnostic accuracy 
[19, 20]. In this study, a score > 11 points on the 
BDI and a score > 10 on the HDRS21 was used to 
indicate the presence of depressive symptoma-
tology.
All patients were evaluated on four occasions: 
one day prior to the procedure, and at 1,  and 12 
month intervals subsequent to the intervention.
A statistical analysis was preformed using the 
Wilcoxon test for paired variables and the Mann 
1  Permission by Quality Metric, Inc., was obtained.
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Whitney “U” Test for unpaired variables. Spear-
man’s rank correlation coefficients were calcu-
lated to permit examination of the association 
between QOL and severity of depressive symp-
toms. All statistical tests were two-sided. A p val-
ue of < 0.05 was considered to be statistically sig-
nificant.
ReSULtS
Demographic	data
Of 227 patients enrolled, 71 were excluded be-
cause of: suboptimal result of PCI (n=31); hospi-
talizations due to non-cardiological reasons dur-
ing the one-year follow-up (n=14), compliance 
failure (n=2). The final group consisted of 15 
patients (39–71 year-old; mean age: 55.05±8.25) 
including: 135 males (8.5%) and 21 females 
(13.5%), who were followed up for one year. 115 
subjects (73.3%) had a previous history of car-
diac infarction. According to the CAD risk fac-
tors: 108 of patients (9%) had hiperlipidemia, 
97 (2%) were diagnosed with hypertension 
and 19 (12%) with diabetes, type II. 70 patients 
(45%) were smokers. In 12 patients (81%) angi-
oplasty was performed as a one-stage procedure, 
in 27 (17%) it was two-stage. 3 patients (2%) had 
a three-stage procedure. One-vessel PTCA was 
performed in 78 subjects (50%), two-vessel in 72 
patients (4%), and three-vessel in  (4%).
After the PCI, patients were treated with: ace-
tylsalicic acid (95%), ticlopidine or clopidogrel 
(90%), statines (2%). Patients with hyperten-
sion, or lowered ejection fractions of the left ven-
tricle received ß-blockers (5%), ACE (spell out)-
inhibitors (8%) or nitrates (24%).
Quality	of	life	and	severity	of	depressive	
symptoms
In the entire group of patients studied (n=15), 
there were no significant correlations between 
cardiovascular function impairment (CCS cri-
teria) and severity of depressive symptoms, as-
sessed with HDRS or BDI; (Spearman rank cor-
relation, HDRS vs. CCS r=0.25 ; BDI vs. CCS 
r=0.27). In the entire study group (n = 15), 
SF scoring one day before the PCI (SF1) was 
45.43±14.75 and there was a significant cor-
relation between the QOL and severity of de-
pressive symptoms assessed with BDI (Spear-
man rank correlation, r= –0.72, p<0.001). The 
QOL one month after the PCI (SF2) was signifi-
cantly improved: (SF1 = 45.43± 14.75 vs. SF2 = 
59.24±14.47, p<0.001, Wilcoxon test for paired 
variables). This tendency persisted at the third 
(SF3 = 55.15±1.70, SF1 vs. SF3 p< 0.05, Wil-
coxon test) and fourth examinations (SF4 = 
55.82±15.75, SF1 vs. SF4 p<0.05, Wilcoxon test); 
however QOL at six months subsequent to the 
PCI was significantly worse than at the second 
examination period (SF3 vs. SF2, p< 0.05, Wil-
coxon).
The presence or absence of depressive symp-
tomatology during the first examination was the 
defining criterion for group I (n=75, 48.1%) – pa-
tients who experienced depressive symptoms be-
fore PCI and II (n=81, 51.9%) – patients without 
the symptoms of depression prior to interven-
tion. One month after the PCI (second exami-
nation), depressive symptoms were observed in 
45 patients (28.9%). Depressive symptoms were 
still present in 33 subjects from group I, while 
in the remainder of group I (n=42) spontane-
ous improvement was observed. Moreover, in 
group II (patients free of depressive symptoms 
one day before PCI) twelve patients developed 
depressive symptomatology during the 4 weeks 
after the procedure. Based on those findings, the 
following subgroups were identified for further 
analysis: Ia (n=33) – patients with depressive 
symptoms persisting for one month, Ib (n=42) – 
patients in whom depressive symptoms abated, 
IIa (n=12) – patients without depressive symp-
toms before PCI in whom depressive symptoms 
developed prior to the second examination, IIb 
(n=42) – patients without depressive symptoms 
both before and one month after PCI.
During each examination the QOL in group 
I was significantly poorer than in group II. (Fig.1, 
Tab 1).
The QOL in group I one month after PCI 
(SF2) was significantly improved (SF1 vs. SF2, 
p<0.001). This trend persisted at the third ex-
amination (SF2 vs. SF3 p< 0.001). One year after 
PCI, QOL was not significantly better than it was 
by the third examination (SF4 vs. SF3, p=NS). In 
group II, by the second examination the QOL 
had significantly improved (SF1 vs. SF2, p< 
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Fig.	1.	The results of SF–36 obtained by patients with depressive symptoms (group I) and patients without depressive symptoms 
(group II) one day prior to the PCI procedure (1), and at one (2), six (3) and twelve month (4) intervals subsequent to the inter-
vention.
table1.	The results of SF–36 obtained by patients with depres-
sive symptoms (group I) and patients without depressive symp-
toms (group II) one day prior to the PCI procedure (SF1), and 
at one (SF2), six (SF3) and twelve (SF4) month intervals subse-
quent to the intervention. Mean value + SD.
Group I Group II p*
SF1 35.4 ± 8.50 54.7 ± 13.2 p< 0.001
SF2 54.2 ± 15.9 63.9 ± 11.3 p< 0.001
SF3 47.2 ± 16.1 62.5 ± 13.7 p< 0.001
SF4 47.6 ± 12.9 63.4 ± 14.3 p< 0.001
*Mann-Whitney U test
0.001) and remained at the same level until the 
end of the follow-up (SF2 vs. SF3, p=NS; SF3 
vs. SF4, p=NS), (Wilcoxon test for paired vari-
ables).
In subgroup Ia the QOL significantly improved 
after PCI, but the degree of this improvement 
was much smaller than in subgroup Ib. The to-
tal quality of life in subgroup Ia was stable dur-
ing all examinations and was poorer than in sub-
table	2.	The differences between results of SF–36 obtained 
one day prior to the PCI procedure (SF1), and at one (SF2), 
six (SF3) and twelve (SF4) month intervals subsequent to the 
intervention by patients with depressive symptoms persisting 
one month after PCI (subgroup Ia) and patients in whom de-
pressive symptoms abated one month after PCI (subgroup Ib). 
Mean value + SD
Subgroup p*
SF1 vs. SF2 Ia p< 0.001 
SF2 vs. SF3 Ia NS
SF3 vs. SF4 Ia NS 
SF1 vs. SF2 Ib p< 0.001
SF2 vs. SF3 Ib p< 0.05 
SF3 vs. SF4 Ib NS
*Wilcoxon test for paired variables
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Fig.	2.	Results of SF–36 obtained by patients with depressive symptoms persisting one month after PCI (subgroup Ia) and patients 
in whom depressive symptoms abated one month after PCI (subgroup Ib) one day prior to the PCI procedure (1), and at one (2), 
six (3) and twelve (4) month intervals subsequent to the intervention.
group Ib, whereas in subgroup Ib the QOL dete-
riorated at  and 12 months (Fig.2). Results of the 
Wilcoxon test for paired variables in sugroups Ia 
and Ib are presented in Tab. 2.
In subgroup IIa the QOL at one day prior to 
the PCI was significantly worse than in subgroup 
IIb. The quality of life in both subgroups had sig-
nificantly improved by the second examination, 
but the degree of this improvement was much 
bigger in subgroup IIb, in which QOL remained 
unchanged for the remainder of the follow-up. 
Six months after PCI, despite a high rate of BDI, 
QOL in subgroup IIa improved when compared 
to the second examination and was not signifi-
cantly different from subgroup IIb. However, af-
ter one year there was a worsening of the QOL 
in subgroup IIa, which was not observed in sub-
group IIb. (Tab.3, Fig.3).
DISCUSSIon	AnD	ConCLUSIonS
Cardiac revascularisation procedures in patients 
with CAD proved to be highly effective in terms 
of immediate relief of angina symptoms, signif-
icant improvement of the patients’ QOL and 
their return to work activities [, 7, 8]. In this 
study we also report a significant improvement 
table	3.	The differences between results of SF–36 obtained 
one day prior to the PCI procedure (SF1), and at one (SF2), six 
(SF3) and twelve (SF4) month intervals subsequent to the in-
tervention by patients without depressive symptoms before PCI 
in whom depressive symptoms developed prior to the second 
examination (subgroup IIa) and patients without depressive 
symptomatology both before and one month after PCI (sub-
group IIb). Mean value + SD
Subgroup p*
SF1 vs. SF2 IIa p<0.05 
SF2 vs. SF3 IIa p<0.05
SF3 vs. SF4 IIa p<0.05
SF1 vs. SF2 IIb p<0.001
SF2 vs. SF3 IIb NS
SF3 vs. SF4 IIb NS
*Wilcoxon test for paired variables
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in the QOL: one, six and twelve months after the 
successful PCI with the entire study group.
However, in some reports the patients – imme-
diately after the cardiac intervention as well as 
at six or twelve months follow-up – complained 
about their general sense of well-being and life 
situation, despite the positive result of the treat-
ment [21, 22, 23]. In the group of patients qual-
ified for coronary artery bypass grafting, it ap-
peared that the individuals prone to react with 
high intensity of stress and psychopathological 
symptoms (anxiety, depression, psychosis) be-
fore the operation, held negative evaluation of 
their general sense of well-being and health con-
dition both before CABG and in the long-term 
follow-up [21].
In our study, mood assessment made one day 
prior to the PCI revealed the presence of de-
pressive symptoms in 48.1% of patients (group 
I). Their QOL was significantly worse one day 
before the intervention and one, six and twelve 
months after when compared to non-depressive 
subjects (group II). Obviously, depressive symp-
toms occurring just prior to the angioplasty may 
be treated as an emotional reaction to the expect-
ed invasive intervention. These symptoms can 
be short-lasting, of mild intensity and may dis-
appear spontaneously, as in the 42 patients (sub-
group Ib) in our study. Consequently, the dis-
appearance of depressive symptoms resulted 
in a stable improvement in the QOL observed 
at all examinations during the one year follow-
up. However, in the 33 patients (subgroup Ia) 
whose depressive symptoms were initially more 
intense, and persisted for four weeks after the 
PCI, improvement of the QOL was present, but 
it was significantly poorer than in subgroup Ib, 
in spite of a similarly optimal result of the cor-
onary angioplasty I both subgroups. Moreover, 
in subgroup Ib the QOL had deteriorated by  
and 12 months.
According to the illusion theory and depres-
sive realism theory, the sudden and great im-
provement in the QOL and depressive symp-
tomatology in subgroup Ib may be accounted 
for by a transient euphoric and over-optimistic 
perception of the world and personal capabili-
ties immediately after successful PCI in those pa-
tients who later become more aware of the situ-
ation. In contrast, depressive patients (subgroup 
Fig.	3.	Results of SF–36 obtained by patients in whom depressive symptoms developed prior to the second examination (subgroup 
IIa) and patients without depressive symptomatology both before and one month after PCI (subgroup IIb)one day prior to the PCI 
procedure (1), and at one (2), six (3) and twelve (4) month intervals subsequent to the intervention.
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Ia) are more moderate and stable in their percep-
tion of life. Additionally, it seems that the mark-
ers of improvement of patients’ somatic state are 
not always related to their QOL [24, 25].
Recently, depressive disorders have become 
a major object of interest for the psychosomat-
ic aspects of heart disease. Numerous studies 
have shown that widely defined depressogen-
ic factors are a significant risk for CAD and oc-
cur in a large group of CAD patients. Depressive 
symptoms occur in 5% of patients subsequent 
to myocardial infarction and their duration and 
intensity meets the DSM-IV criteria for major de-
pression in 1–22% of cases [2, 27, 28]. This re-
sult confirms the necessity of a holistic approach 
to CAD treatment, also giving attention to the 
mental state of patients frequently subjected to 
contemporary revascularization procedures. Al-
though comorbidity of depression and CAD is 
an important clinical problem, depressive disor-
ders are rarely diagnosed and treated in cardiac 
patients [11, 29].
The results derived from the present study sug-
gest that the pre-existence of depressive symp-
toms may contribute to the lack of significant im-
provement of QOL after a successful PCI. A pa-
tient, who presents with a higher level of bigger 
severity of depression, anxiety or distress prior to 
the intervention, requires special attention. De-
pressive symptomatology may persist even one 
year subsequent to the intervention and no im-
provement of QOL could be observed despite 
the patient’s optimal cardiac profile.
Limitations	of	the	study
The study was focused on depressive symptoms 
but not on the detection of depressive episode 
and its relationships with QOL. Assessment of 
depressive symptoms one day before PCI with-
out information about symptoms duration didn’t 
give the possibility for diagnosing of depression. 
It may be hypothesized that part of the so called 
depressive symptoms may be related with anx-
iety before PCI.
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